MX2018015101A - Composiciones de polisacaridos para la reparacion de tejidos. - Google Patents

Composiciones de polisacaridos para la reparacion de tejidos.

Info

Publication number
MX2018015101A
MX2018015101A MX2018015101A MX2018015101A MX2018015101A MX 2018015101 A MX2018015101 A MX 2018015101A MX 2018015101 A MX2018015101 A MX 2018015101A MX 2018015101 A MX2018015101 A MX 2018015101A MX 2018015101 A MX2018015101 A MX 2018015101A
Authority
MX
Mexico
Prior art keywords
tissue repair
polysaccharide compositions
fibrotic
processes
tissue
Prior art date
Application number
MX2018015101A
Other languages
English (en)
Inventor
Callegaro Lanfranco
Brun Paola
Bianchini Giulio
Original Assignee
Jointherapeutics S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jointherapeutics S R L filed Critical Jointherapeutics S R L
Publication of MX2018015101A publication Critical patent/MX2018015101A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

La presente invención se refiere a composiciones de polisacáridos que se pueden usar como moduladores de procesos de proliferación celular y su uso en la reparación de tejidos con inhibición del proceso fibrótico. Estas propiedades de modulación se pueden usar de manera útil en la reparación de tejidos para la prevención de procesos fibróticos y/o adhesiones de tejidos en procesos fibróticos traumáticos, postquirúrgicos y crónicos asociados a enfermedades autoinmunes.
MX2018015101A 2016-06-07 2017-06-06 Composiciones de polisacaridos para la reparacion de tejidos. MX2018015101A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITUA2016A004153A ITUA20164153A1 (it) 2016-06-07 2016-06-07 Composizioni polisaccaridiche impiegabili nella riparazione tissutale
PCT/EP2017/063639 WO2017211776A1 (en) 2016-06-07 2017-06-06 Polysaccharide compositions for tissue repair

Publications (1)

Publication Number Publication Date
MX2018015101A true MX2018015101A (es) 2019-05-06

Family

ID=57113588

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018015101A MX2018015101A (es) 2016-06-07 2017-06-06 Composiciones de polisacaridos para la reparacion de tejidos.

Country Status (9)

Country Link
US (1) US11116787B2 (es)
EP (1) EP3463392B1 (es)
CN (1) CN109310706A (es)
CA (1) CA3025989A1 (es)
ES (1) ES2928087T3 (es)
IT (1) ITUA20164153A1 (es)
MX (1) MX2018015101A (es)
RU (1) RU2760358C2 (es)
WO (1) WO2017211776A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700060530A1 (it) * 2017-06-01 2018-12-01 Jointherapeutics S R L Derivati polisaccaridici idrosolubili, loro procedimento di preparazione e loro usi
IT201700111939A1 (it) * 2017-10-05 2019-04-05 Jointherapeutics S R L Composizione farmaceutica per l’uso nel trattamento di stati infiammatori
IT201900006250A1 (it) 2019-04-23 2020-10-23 Fidia Farm Spa Medicazione per il trattamento della cute lesa
IT202000007372A1 (it) * 2020-04-07 2021-10-07 Jointherapeutics S R L Materiale polimerico reticolato, comprendente almeno un chitosano funzionalizzato, e suo uso nel trattamento di stati infiammatori
CN113045760B (zh) * 2021-04-12 2022-03-25 华南理工大学 一种基于透明质酸和α-D-半乳糖的聚合物刷及其制备方法和应用
IT202100010187A1 (it) * 2021-04-22 2022-10-22 Jointherapeutics S R L Uso di chitosano funzionalizzato nel trattamento di patologie infiammatorio-fibrotiche del tratto respiratorio e epatiche

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0059015B2 (en) 1981-02-24 1989-05-17 THE PROCTER & GAMBLE COMPANY Disposable absorbent article having an improved liquid migration resistant perimeter construction
US4424346A (en) 1981-06-04 1984-01-03 Canadian Patents And Development Ltd. Derivatives of chitins, chitosans and other polysaccharides
DE3482812D1 (de) 1983-10-11 1990-08-30 Fidia Spa Fraktionen von hyaluronsaeure mit pharmazeutischer aktivitaet, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
IL123500A (en) * 1995-08-29 2003-06-24 Fidia Advanced Biopolymers Srl Composite biomaterials for preventing post-surgical adhesions of tissues
DE60014400T2 (de) 1999-07-28 2005-10-06 United States Surgical Corp., Norwalk Antiadhäsionsschicht aus hyaluronsäure
US7700819B2 (en) * 2001-02-16 2010-04-20 Kci Licensing, Inc. Biocompatible wound dressing
ITPD20040053A1 (it) * 2004-02-27 2004-05-27 Fidia Advanced Biopolymers Srl Biomateriali costituiti da derivati dell'acido ialuronico come nuova terapia di cura per la protezione e la la riparazione della cartilagine articolare danneggiata per osteoartrosi
ITRM20040539A1 (it) * 2004-11-02 2005-02-02 Mavi Sud S R L Preparati a base di chitina o suoi derivati per uso cosmetico o medico.
ITPD20060202A1 (it) * 2006-05-22 2007-11-23 Univ Degli Studi Trieste Miscele polimeriche di polisaccaridi anionici e cationici e loro impiego
US9597277B2 (en) * 2006-12-22 2017-03-21 Croma-Pharma Gesellschaft M.B.H. Use of polymers
WO2010003797A1 (en) 2008-07-09 2010-01-14 Novozymes Biopharma Dk A/S Hyaluronic acid for corneal wound healing
CN101897990B (zh) * 2010-07-06 2013-01-02 大连理工大学 一种用于抑制瘢痕促进伤口快速愈合敷料组合物及应用
IT1401498B1 (it) 2010-07-30 2013-07-26 Mero Srl Idrogelo a base di acido ialuronico e suo uso in ortopedia
CN102210885B (zh) * 2011-06-06 2013-08-07 深港产学研基地 高透气性可降解的载药皮肤创伤敷料及其制备方法和设备
KR101598329B1 (ko) 2013-03-20 2016-02-29 일동제약주식회사 히알루론산의 제조방법 및 상기 제조방법으로 제조된 히알루론산을 포함하는 유착방지용 조성물
CA2956658C (en) * 2013-07-30 2021-03-02 Oligo Medic Inc. Composition comprising polyglucosamine-glyoxylate solutions mixed with hyaluronan

Also Published As

Publication number Publication date
EP3463392A1 (en) 2019-04-10
RU2018141365A (ru) 2020-07-09
WO2017211776A1 (en) 2017-12-14
ITUA20164153A1 (it) 2017-12-07
US20200306288A1 (en) 2020-10-01
RU2018141365A3 (es) 2020-09-17
ES2928087T3 (es) 2022-11-15
CN109310706A (zh) 2019-02-05
US11116787B2 (en) 2021-09-14
EP3463392B1 (en) 2022-07-06
RU2760358C2 (ru) 2021-11-24
CA3025989A1 (en) 2017-12-14

Similar Documents

Publication Publication Date Title
MX2018015101A (es) Composiciones de polisacaridos para la reparacion de tejidos.
PH12019502810A1 (en) Bicyclic heterocycles as fgfr inhibitors
PH12017501481B1 (en) Bicyclic heterocycles as fgfr inhibitors
EP3785728A3 (en) Use of myostatin inhibitors and combination therapies
MX2021014739A (es) Fosfinimida de titanio y sistemas de catalizadores de iminoimidazolidida de titanio con soportes de activador.
PH12017501483A1 (en) Bicyclic heterocycles as fgfr4 inhibitors
WO2016029191A3 (en) Channel modulators
MX2017012206A (es) Proliferacion ex vivo de celulas epiteliales.
PH12016501985A1 (en) Rapid set aqueous coatings
MX2019015311A (es) Composiciones de ésteres de ácido cannabidiólico y usos de las mismas.
MX2017006015A (es) Composiciones para usar en el tratamiento de cancer renal.
AU363923S (en) Speakerphone
MX2018000715A (es) Metodos para tratar cancer usando apilimod.
TN2017000465A1 (en) The use of sgc stimulators, sgc activators, alone and combinations with pde5 inhibitors for the treatment of digital ulcers (du) concomitant to systemic sclerosis (ssc)
EP4233926A3 (en) Methods of manufacturing injectable gels comprising cross-linked hyaluronic acid and hydroxyapatite
MX2017006026A (es) Apilimod para uso en el tratamiento de cancer colorrectal.
MX2016010229A (es) Conjugados del factor vii.
PH12016501658A1 (en) Sialylated glycoprotein compositions and uses thereof
MX2020002147A (es) Composiciones útiles para la mejora del dolor.
MX366893B (es) Determinación del grado de ramificación.
WO2019028012A3 (en) METHODS OF USING PEMBROLIZUMAB AND TREBANANIB
MX2018011512A (es) Uso de insulina para promover el vaciamiento gástrico.
EP3364942A4 (en) KITS AND METHODS OF USING ASCORBATES TO MODIFY POLYSACCHARIDE LOADS AND ADMINISTRATION SYSTEMS
AU364002S (en) Bus
AU356412S (en) Handset